XBI-302
N/A
Report date: 2026/02/28 20:00:37
Base Information
Drug NameXBI-302
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[8]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Xbiome Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShenzhen Xbiome Biotechnology Co LtdPeking UniversityPeking University Sixth Hospital +[4]
Inactive CompaniesN/A
Active Indications +[8]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A